Anebulo Historical Income Statement

ANEB Stock  USD 1.43  0.03  2.14%   
Historical analysis of Anebulo Pharmaceuticals income statement accounts such as Depreciation And Amortization of 245.4 K, Interest Expense of 158.8 K or Selling General Administrative of 3.6 M can show how well Anebulo Pharmaceuticals performed in making a profits. Evaluating Anebulo Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Anebulo Pharmaceuticals's future profits or losses.

Anebulo Pharmaceuticals Net Income

(8.61 Million)

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.

About Anebulo Income Statement Analysis

Anebulo Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Anebulo Pharmaceuticals shareholders. The income statement also shows Anebulo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Anebulo Pharmaceuticals Income Statement Chart

At present, Anebulo Pharmaceuticals' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 158.8 K, whereas Depreciation And Amortization is forecasted to decline to about 245.4 K.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anebulo Pharmaceuticals. It is also known as Anebulo Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Anebulo Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Anebulo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.At present, Anebulo Pharmaceuticals' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 158.8 K, whereas Depreciation And Amortization is forecasted to decline to about 245.4 K.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization6.8M11.8K258.3K245.4K
Interest Income92.4K147.6K249.0K261.5K

Anebulo Pharmaceuticals income statement Correlations

-0.130.890.85-0.80.83-0.88-0.250.8-0.290.83-0.320.14-0.32-0.930.86-0.59
-0.13-0.240.1-0.320.11-0.08-0.340.11-0.150.11-0.34-0.36-0.340.340.05-0.4
0.89-0.240.54-0.60.52-0.59-0.190.49-0.250.52-0.240.06-0.24-0.720.53-0.18
0.850.10.54-0.891.0-0.99-0.40.98-0.411.0-0.480.01-0.48-0.890.98-0.87
-0.8-0.32-0.6-0.89-0.910.920.71-0.920.68-0.910.770.370.770.71-0.830.73
0.830.110.521.0-0.91-0.99-0.480.99-0.481.0-0.55-0.07-0.55-0.870.97-0.86
-0.88-0.08-0.59-0.990.92-0.990.47-0.990.48-0.990.540.060.540.89-0.970.84
-0.25-0.34-0.19-0.40.71-0.480.47-0.550.98-0.481.00.911.00.19-0.270.23
0.80.110.490.98-0.920.99-0.99-0.55-0.560.99-0.62-0.15-0.62-0.850.95-0.84
-0.29-0.15-0.25-0.410.68-0.480.480.98-0.56-0.480.980.880.980.27-0.270.16
0.830.110.521.0-0.911.0-0.99-0.480.99-0.48-0.55-0.07-0.55-0.870.97-0.86
-0.32-0.34-0.24-0.480.77-0.550.541.0-0.620.98-0.550.871.00.26-0.350.3
0.14-0.360.060.010.37-0.070.060.91-0.150.88-0.070.870.87-0.220.16-0.14
-0.32-0.34-0.24-0.480.77-0.550.541.0-0.620.98-0.551.00.870.26-0.350.3
-0.930.34-0.72-0.890.71-0.870.890.19-0.850.27-0.870.26-0.220.26-0.910.63
0.860.050.530.98-0.830.97-0.97-0.270.95-0.270.97-0.350.16-0.35-0.91-0.89
-0.59-0.4-0.18-0.870.73-0.860.840.23-0.840.16-0.860.3-0.140.30.63-0.89
Click cells to compare fundamentals

Anebulo Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Anebulo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anebulo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anebulo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anebulo Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Return On Assets
(0.66)
Return On Equity
(1.14)
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.